Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ACET vs SHPD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ACET Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 6–2 Matrix Metrics)

ACET Overall Winner 6-Pillar Tally: ACET 4 – 1 SHPD (1 Tie) Matrix Metrics: ACET 6 – 2 SHPD

As of Nov 16, 2026, Adicet Bio, Inc. (ACET) is the stronger overall head-to-head candidate over Direxion Daily SHOP Bear 1X ETF (SHPD) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ACET carries a Unified Composite Score of 46.7/100 (HOLD) at $2.75 (N/M Forward P/E, 0.0% operating margin), whereas SHPD carries 60.0/100 (BUY) at $23.55 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While SHPD currently prints a higher short-term Unified Composite Score (60.0/100 BUY vs. ACET 46.7/100 HOLD), ACET captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (0.0% vs. N/A operating margin) and revenue trajectory (-100.0% vs. N/A YoY).
  • Technical & Structure Timing Caution: ACET is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 17.4); meanwhile SHPD trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 58.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ACET vs SHPD
ACET NASDAQ Head-to-Head Winner
Adicet Bio, Inc. Common Stock
Pharmaceutical Preparations
$2.75
-1.08% 1D
Market Cap $26.0M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.90β · 45% Vol
Unified Composite Score
46.7 / 100 HOLD
Tech 45.0 Fund 48.0 Flow 67.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -27.4%), weak momentum, RSI 17
RSI-14: 17.4 · SMA20: $3.44 · SMA50: $5.80
SHPD NASDAQ
Direxion Daily SHOP Bear 1X ETF
Institutional Equity
$23.55
+1.31% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -2.40β · 48% Vol
Unified Composite Score
60.0 / 100 BUY
Tech 75.0 Fund 62.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (7.4% over 20 days), RSI 59
RSI-14: 58.9 · SMA20: $22.30 · SMA50: $22.22

6-Pillar Scorecard Institutional Category Breakdown (ACET 4 – 1 SHPD)

Columns: Metric · ACET · SHPD
1. Valuation Multiples ACET
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio 0.82x N/M
EV / Revenue N/M N/M
2. Growth & Scale ACET
Revenue Growth (YoY) -100.0% N/A
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) N/A N/A
Market Cap $26.0M N/A
3. Profitability & Quality ACET
Gross Margin N/A N/A
Operating Margin 0.0% N/A
Net Profit Margin 0.0% N/A
Return on Equity (ROE) -85.9% N/A
4. Balance Sheet & Cash Flow ACET
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $15M Net Cash N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning SHPD
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 84.5% (6th %ile) N/A (N/A)
Put/Call OI Skew 1.22x (Put-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ACET (6) vs SHPD (2)
Institutional Metric ACET SHPD Criterion Row Edge
Market Capitalization
Scale
$26.0M N/A Larger Scale ACET
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-100.0% N/A Higher Growth ACET
Operating Margin (TTM)
Profitability
0.0% N/A Higher Margin ACET
Net Profit Margin
Profitability
0.0% N/A Higher Margin ACET
Return on Equity (ROE)
Capital Efficiency
-85.9% N/A Higher ROE ACET
52-Week Range Position
Momentum
24% ($0–$10) 78% ($16–$26) Stronger Trend SHPD
Beta / 30D Volatility
Risk Regime
1.90β · 45% Vol -2.40β · 48% Vol Lower Realized Risk ACET
Unified Institutional Score
Composite Signal
46.7 / 100 (HOLD) 60.0 / 100 (BUY) Higher Composite SHPD
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.82x PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($15M Net Cash) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SHPD +23.93 pp
ACET: -9.5% · SHPD: +14.43%
3M Horizon SHPD +55.66 pp
ACET: -16.44% · SHPD: +39.22%
6M Horizon ACET +900.99 pp
ACET: +919.45% · SHPD: +18.46%
1Y Horizon ACET +900.99 pp
ACET: +919.45% · SHPD: +18.46%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACET vs SHPD. Trailing 12-month operating profitability (ACET 0.0% vs SHPD N/A) and valuation multiples (ACET N/M vs SHPD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ACET ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-85.9% · N/M
SHPD ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ACET BREAKDOWN
118d in phase · OBV DISTRIBUTION
Current IV 84.5%
IV Percentile 6th %ile
Put/Call OI Skew 1.22x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact ACET Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SHPD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SHPD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ACET Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $26.0M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
SHPD Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ACET vs SHPD Key Questions & Quantitative Answers

As of Nov 16, 2026, Adicet Bio, Inc. (ACET) is the stronger overall head-to-head candidate over Direxion Daily SHOP Bear 1X ETF (SHPD) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ACET carries a Unified Composite Score of 46.7/100 (HOLD) at $2.75 (N/M Forward P/E, 0.0% operating margin), whereas SHPD carries 60.0/100 (BUY) at $23.55 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While SHPD currently prints a higher short-term Unified Composite Score (60.0/100 BUY vs. ACET 46.7/100 HOLD), ACET captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (0.0% vs. N/A operating margin) and revenue trajectory (-100.0% vs. N/A YoY). Technical & Structure Timing Caution: ACET is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 17.4); meanwhile SHPD trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 58.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ACET leads the Growth & Scale pillar: ACET posts -100.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with SHPD at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, ACET generates N/A in USD-normalized revenue versus N/A for SHPD. In operating R&D and SG&A reinvestment, ACET deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for SHPD.

ACET screens cheaper on headline valuation multiples. ACET trades at N/M Forward P/E, N/M Trailing P/E, 0.82x PEG, and N/M EV/Revenue (unreported cash flow margin), whereas SHPD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ACET (-85.9% ROE) versus SHPD (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, ACET carries 84.5% implied volatility (6th %ile, Compressed (<25th %ile)), a 1.22x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.90β · 45% Vol realized risk). By comparison, SHPD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-2.40β · 48% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.